Clinical staging and histopathological findings after radical hysterectomy in FIGO stage IIB cervical cancer

被引:0
|
作者
Mandic, A. [1 ]
Novakovic, P. [1 ]
Mihajlovic, O. [1 ]
Stojiljkovic, B. [1 ]
Rajovic, J. [1 ]
Davidovic, M. [1 ]
机构
[1] Inst Oncol Vojvodina, Clin Surg Oncol, Dept Gynecol Oncol, Sremska Kamenica 21204, Serbia
来源
JOURNAL OF BUON | 2008年 / 13卷 / 01期
关键词
cervical cancer; clinical stage; nodal disease; parametrial invasion; pathological stage; stage IIB;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Advanced cervical cancer still represents a major health care challenge in the developing world. According to standard protocols the treatment of choice for stage IIB cervical cancer is cisplatin-based chemoradiotherapy. However in some European countries, and especially in Japan, patients with stage IIB cervical cancer are generally treated with radical hysterectomy as initial treatment. The aim of this study was to compare clinical stage with pathological findings, and also to correlate any relationship between parametrial infiltration and nodal status. Patients and methods: From 199 7 to 2006, 26 patients with FIGO stage IIB cervical cancer were radically operated (Piver class III operation). Preoperative clinical findings were compared with the pathological findings of the surgical material. The correlation between infiltration of the parametria and lymph node status was also examined. Fisher exact test was used to examine statistical significance. Results: The patients' median age was 48.3 years (range 36-61). The median number of removed lymph nodes was 16 (range 8-40). The histopathological types of cervical tumors were: squamous cell carcinoma 80%, adenosquamous carcinoma 15% and adenocarcinoma 5%. In 50% of the patients the parametria were infiltrated, suggesting that 50% of the patients were clinically overstaged. Positive lymph nodes were found in 69% of patients with positive parametria and 15% inpatients with negative parametria (p<0.05). Patients with positive lymph nodes received adjuvant chemoradiotherapy. Conclusion: Adequate preoperative staging such as clinical examination under anesthesia or nuclear magnetic resonance could help to exclude parametrial involvement in equivocal cases. Parametrial invasion presents an important risk factor for lymph nodes metastases.
引用
收藏
页码:51 / 54
页数:4
相关论文
共 50 条
  • [1] Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
    Yanlan Chai
    Tao Wang
    Juan Wang
    Yunyi Yang
    Ying Gao
    Jiyong Gao
    Shangfeng Gao
    Yueling Wang
    Xi Zhou
    Zi Liu
    BMC Cancer, 14
  • [2] Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
    Chai, Yanlan
    Wang, Tao
    Wang, Juan
    Yang, Yunyi
    Gao, Ying
    Gao, Jiyong
    Gao, Shangfeng
    Wang, Yueling
    Zhou, Xi
    Liu, Zi
    BMC CANCER, 2014, 14
  • [3] Radical hysterectomy for FIGO stage IIB cervical cancer: Clinicopathological characteristics and prognostic evaluation
    Kasamatsu, Takahiro
    Onda, Takashi
    Sawada, Morio
    Kato, Tomoyasu
    Ikeda, Shun-ichi
    GYNECOLOGIC ONCOLOGY, 2009, 114 (01) : 69 - 74
  • [4] Radical hysterectomy for stage IIB cervical cancer: a review
    Suprasert, P
    Srisomboon, J
    Kasamatsu, T
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (06) : 995 - 1001
  • [5] Radical hysterectomy with adjuvant radiotherapy versus definitive radiotherapy alone for FIGO stage IIB cervical cancer
    Mabuchi, Seiji
    Okazawa, Mika
    Isohashi, Fumiaki
    Matsuo, Koji
    Ohta, Yukinobu
    Suzuki, Osamu
    Yoshioka, Yasuo
    Enomoto, Takayuki
    Kamiura, Shoji
    Kimura, Tadashi
    GYNECOLOGIC ONCOLOGY, 2011, 123 (02) : 241 - 247
  • [6] Propensity Score Analysis of Radical Hysterectomy Versus Definitive Chemoradiation for FIGO Stage IIB Cervical Cancer
    Tomita, Natsuo
    Mizuno, Mika
    Makita, Chiyoko
    Kondo, Shinji
    Mori, Masahiko
    Sakata, Jun
    Tsubouchi, Hirofumi
    Hirata, Kimiko
    Tachibana, Hiroyuki
    Kodaira, Takeshi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1576 - 1583
  • [7] Cost-effectiveness of radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
    Chai, Yanlan
    Wang, Juan
    Wang, Tao
    Shi, Fan
    Wang, Jiquan
    Su, Jin
    Yang, Yunyi
    Zhou, Xi
    Ma, Hailin
    He, Bin
    Liu, Zi
    ONCOTARGETS AND THERAPY, 2016, 9 : 349 - 354
  • [8] Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix
    T Kasamatsu
    T Onda
    M Sawada
    T Kato
    S Ikeda
    Y Sasajima
    H Tsuda
    British Journal of Cancer, 2009, 100 : 1400 - 1405
  • [9] Outcomes of Minimally Invasive versus Open Radical Hysterectomy for Early Stage Cervical Cancer Incorporating 2018 FIGO Staging
    Levine, Monica D.
    Brown, Jubilee
    Crane, Erin K.
    Tait, David L.
    Naumann, R. Wendel
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2021, 28 (04) : 824 - 828
  • [10] Neoadjuvant Chemoradiation Followed by Radical Hysterectomy in FIGO Stage IIIB Cervical Cancer Feasibility, Complications, and Clinical Outcome
    Fanfani, Francesco
    Fagotti, Anna
    Ferrandina, Gabriella
    Raspagliesi, Francesco
    Ditto, Antonino
    Cerrotta, Anna Maria
    Morganti, Alessio
    Smaniotto, Daniela
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (06) : 1119 - 1124